Alternative Pain Management Strategies for Patients on Semaglutide Introduction For patients receiving semaglutide, a GLP-1 receptor agonist pivotal in managing type 2 diabetes and obesity, finding effective pain management strategies that do not compromise the medications efficacy or patient safety is crucial
Atherosclerosis 236 , 717 (2014)
Its use in telogen effluvium is off-label but sometimes recommended
Commonly reported issues include nausea, diarrhea, vomiting, constipation, abdominal (stomach) discomfort and pain, injection site reactions, fatigue, hypersensitivity (allergic) reactions (typically fever and rash), burping, hair loss and gastroesophageal reflux disease
For targeted vitamin support between IV sessions, intramuscular (IM) vitamin injections offer a convenient way to maintain consistent nutrient levels throughout the week
Fast facts table How to Prevent Semaglutide-Related Weight Gain You can maintain results with smart dosing, muscle-first training, protein-forward nutrition, daily movement, and data tracking